These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6352644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
    Fainstein V, Bodey GP, Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():101-10. PubMed ID: 6352612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients.
    Reilly JT, Brada M, Bellingham AJ, Hart CA, Bennet C.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():89-92. PubMed ID: 6352660
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [Abstract] [Full Text] [Related]

  • 9. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L, Wells H, Lange BJ.
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [Abstract] [Full Text] [Related]

  • 10. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G, Arlet G, Bancillon A, Schaison G.
    Presse Med; 1988 Oct 26; 17(37):1974-6. PubMed ID: 2973600
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
    Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J.
    N Engl J Med; 1986 Aug 28; 315(9):552-8. PubMed ID: 3526155
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP, Bru JP, Michallet M, Corron B, Fauconnier J.
    Presse Med; 1988 Oct 26; 17(37):1964-7. PubMed ID: 2973597
    [Abstract] [Full Text] [Related]

  • 16. A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.
    Gibson J, Johnson L, Snowdon L, Joshua D, Young G, MacLeod C, Iland H, Vincent P, Kronenberg H.
    Int J Hematol; 1994 Aug 26; 60(2):119-27. PubMed ID: 7948961
    [Abstract] [Full Text] [Related]

  • 17. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP.
    Ann Intern Med; 1994 May 15; 120(10):834-44. PubMed ID: 8154643
    [Abstract] [Full Text] [Related]

  • 18. Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
    Rhodes EG, Harris RI, Welch RS, Perry DJ, Brown RM, Boughton BJ.
    J Hosp Infect; 1987 May 15; 9(3):278-84. PubMed ID: 2886533
    [Abstract] [Full Text] [Related]

  • 19. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
    Bezwoda WR, Derman DP, Perkins S, Cassel R.
    J Antimicrob Chemother; 1985 Feb 15; 15(2):239-45. PubMed ID: 3884566
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L, Devecioglu O, Anak S, Karakas Z, Yalman N, Biner B, Eryilmaz E, Goksan B, Unuvar A, Agirbasli H, Can M, Bilgen H, Gedikoglu G.
    J Chemother; 2001 Jun 15; 13(3):281-7. PubMed ID: 11450887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.